{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:41:17Z","timestamp":1770982877346,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011946","name":"Abbott Diabetes Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.eprac.2022.02.004","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T03:23:46Z","timestamp":1644636226000},"page":"472-478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Flash Glucose Monitoring in Israel: Understanding Real-World Associations between Self-Monitoring Frequency and Metrics of Glycemic Control"],"prefix":"10.1016","volume":"28","author":[{"given":"Roy","family":"Eldor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eytan","family":"Roitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Merzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoel","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Tsur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.eprac.2022.02.004_bib1","first-page":"S73","article-title":"6. Glycemic Targets: Standards of medical care in diabetes\u20142021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.eprac.2022.02.004_bib2","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2337\/dc12-1770","article-title":"Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants","volume":"36","author":"Miller","year":"2013","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.eprac.2022.02.004_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-2006-924152","article-title":"Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria","volume":"114","author":"Sch\u00fctt","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.eprac.2022.02.004_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40200-015-0172-z","article-title":"Patient perspectives on self-monitoring of blood glucose: perceived recommendations, behaviors and barriers in a clinic sample of adults with type 2 diabetes","volume":"14","author":"Ward","year":"2015","journal-title":"J\u00a0Diabetes Metab Disord"},{"issue":"4","key":"10.1016\/j.eprac.2022.02.004_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial","volume":"317","author":"Beck","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.eprac.2022.02.004_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/M16-2855","article-title":"Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: A randomized trial","volume":"167","author":"Beck","year":"2017","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.eprac.2022.02.004_bib7","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.2337\/dc20-0738","article-title":"Effect of flash glucose monitoring on glycemic control, hypoglycemia, diabetes-related distress, and resource utilization in the Association of British Clinical Diabetologists (ABCD) nationwide audit","volume":"43","author":"Deshmukh","year":"2020","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2022.02.004_bib8","first-page":"S85","article-title":"7. Diabetes technology: standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2022.02.004_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/dia.2014.0378","article-title":"The performance and usability of a factory-calibrated flash glucose monitoring system","volume":"17","author":"Bailey","year":"2015","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"10.1016\/j.eprac.2022.02.004_bib10","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.eprac.2022.02.004_bib11","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.2337\/dci18-0010","article-title":"Need for regulatory change to incorporate beyond a1c glycemic metrics","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.eprac.2022.02.004_bib12","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2022.02.004_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.diabres.2017.12.015","article-title":"Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: a European analysis of over 60 million glucose tests","volume":"137","author":"Dunn","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"10.1016\/j.eprac.2022.02.004_bib14","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2337\/dc08-0545","article-title":"Translating the A1C assay into estimated average glucose values","volume":"31","author":"Nathan","year":"2008","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2022.02.004_bib15","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.2337\/dc18-1581","article-title":"Glucose Management Indicator (GMI): A new term for estimating A1c from continuous glucose monitoring","volume":"41","author":"Bergenstal","year":"2018","journal-title":"Diabetes Care"},{"issue":"10057","key":"10.1016\/j.eprac.2022.02.004_bib16","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/S0140-6736(16)31535-5","article-title":"Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial","volume":"388","author":"Bolinder","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eprac.2022.02.004_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13300-016-0223-6","article-title":"Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: A multicenter, open-label randomized controlled trial","volume":"8","author":"Haak","year":"2017","journal-title":"Diabetes Ther"},{"issue":"3","key":"10.1016\/j.eprac.2022.02.004_bib18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/1932296819838534","article-title":"Comment on Grino et\u00a0al: Suitability of flash glucose monitoring for detection of hypoglycemia","volume":"13","author":"Seibold","year":"2019","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.eprac.2022.02.004_bib19","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1177\/1932296816653412","article-title":"Improvement in glucose control in difficult-to-control patients with diabetes using a novel flash glucose monitoring device","volume":"10","author":"Ish-Shalom","year":"2016","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"7","key":"10.1016\/j.eprac.2022.02.004_bib20","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2337\/dc18-0166","article-title":"Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes","volume":"42","author":"Yaron","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2022.02.004_bib21","doi-asserted-by":"crossref","first-page":"e3355","DOI":"10.1002\/dmrr.3355","article-title":"Impact of flash glucose monitoring on glucose control and hospitalization in type 1 diabetes: A nationwide cohort study","volume":"37","author":"Tsur","year":"2021","journal-title":"Diabetes Metab Res Rev"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22000453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22000453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:12:13Z","timestamp":1761516733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X22000453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1530891X22000453"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.02.004","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flash Glucose Monitoring in Israel: Understanding Real-World Associations between Self-Monitoring Frequency and Metrics of Glycemic Control","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}